Cephalon Inc. has issued a recall of Treanda, an injection used to treat leukemia, after glass fragments were found by the U.S. Food and Drug Administration in one vial of the medication.
According to the FDA, glass fragments in the medication can increase the risk of a number of adverse medical side effects, including the disruption of blood flow and tissue/organ damage.
The recall is in effect for Injection 15mg/8mL, lot TB30111 with the expiration date of December 2012, which was distributed nationwide between March 22, 2011 and October 5, 2011.
Treanda (bendamustine HCL) is used to treat chronic lymphocytic leukemia (CLL0) and indolent B-cell non-Hodgkin’s lymphoma.
If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law to find out if a dangerous drug lawyer may be able to help you and represent your case.